Treosulfan Based Conditioning Myelodysplastic Syndrome (MDS)

NCT01062490 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
45
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

medac GmbH